Tuesday, October 10, 2017
Shockwave Medical Finds $35M For Cardiovascular Therapy
Fremont-based Shockwave Medical, a developer of technology to treat calcified plaque that contributes to cardiovascular disease, has raised $35M in an extension of its Series C funding, the company said today
The story you have requested is only available to paid members of the silicontap.com web site. Stories newer than 15 days are restricted to paid members only. Please login in order to access this members-only content, or become a member.